ET HealthWorld1d
AI will not replace doctors, but doctors who know AI will replace those who don’t: Dr D Nageshwar Reddy
Highlighting AI’s role in improving colonoscopy detection, emergency care, and personalized medicine, Dr. D. Nageshwar Reddy, ...
Alvotech and Dr. Reddy’s Announce FDA acceptance of Biologic License Application for AVT03, a Proposed Biosimilar to Prolia® and Xgeva®
“The FDA's filing acceptance of Dr. Reddy's proposed denosumab biosimilar marks an important milestone in bringing this biosimilar medication to more patients throughout the U.S.,” said Milan ...
Dr. Reddy's Laboratories advances Friday, outperforms market
Dr. Reddy's Laboratories Ltd. closed 15.55% below its 52-week high of 1,420.20 rupees, which the company reached on August 21st.
Sunitha Reddy, MBA, MPH, FACHE
Sunitha Reddy, chief revenue officer/vice president of operations at Prime Healthcare, plays a pivotal role in driving ...
Dr. Reddy's Laboratories rises Thursday, outperforms competitors
Dr. Reddy's Laboratories Ltd. closed 16.44% short of its 52-week high of 1,420.20 rupees, which the company reached on August ...
Finalist: Prem Reddy, M.D., FACC, FCCP
Prem Reddy, M.D., FACC, FCCP, is a physician, entrepreneur and philanthropist. Dr. Reddy was born into a family of proud ...
ConsumerAffairs8d
Dr. Reddy’s recalls levetiracetam infusion bags nationwide due to mislabeling
Dr. Reddy’s Laboratories has initiated a voluntary recall of Levetiracetam in 0.75% Sodium Chloride Injection (1,000 mg/100 ...
TipRanks on MSN3d
Dr. Reddy’s, Alvotech announce FDA acceptance of BLA for AVT03
Dr. Reddy’s Laboratories (RDY) and Alvotech (ALVO) announced that the U.S. Food and Drug Administration, FDA, has accepted a 351(k) Biologic ...
Dr Reddys Share Price Live Updates: Dr. Reddy's Laboratories trading volume highlights market interest
Stay up-to-date with the Dr Reddys Stock Liveblog, your comprehensive source for real-time updates and detailed analysis on a ...